Select recent publications by our faculty

Czuczman MS et al. Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy. i2001;12(1):109-14. Abstract

Dang NH et al. Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin’s lymphoma. J Clin Oncol 2004;22(20):4095-102. Abstract

Enschede SH et al. Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline- based regimen in the treatment of aggressive non-Hodgkin’s lymphoma. Leuk Lymphoma 2001;40(3-4):325-34. Abstract

Gopal AK et al. Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin’s lymphoma in adults 60 years of age and older. Bone Marrow Transplant 2001;27(6):593-9. Abstract

Gregory SA. Selecting patients for treatment with 90Y ibritumomab tiuxetan (Zevalin®). Semin Oncol 2003;30(6 Suppl 17):17-22. Abstract

Gregory SA et al. Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin’s lymphoma: Results of a phase II study. Clin Lymphoma 2003;4(2):93-8. Abstract

Gregory SA et al. Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin’s lymphoma failing primary therapy with a doxorubicin or mitoxantrone-containing regimen. Leuk Lymphoma 2001;40(3-4):315-24. Abstract

Gutierrez-Delgado F et al. Autologous stem cell transplantation for non-Hodgkin’s lymphoma: Comparison of radiation-based and chemotherapy-only preparative regimens. Bone Marrow Transplant 2001;28(5):455-61. Abstract

Maloney DG. Graft-vs.-lymphoma effect in various histologies of non-Hodgkin’s lymphoma. Leuk Lymphoma 2003;44(Suppl 3):99-105. Abstract

Maloney DG. Rituximab for follicular lymphoma. Curr Hematol Rep 2003;2(1):13-22. Abstract

Seymour JF et al. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin’s lymphoma. J Clin Oncol 2003;21(11):2115-22. Abstract

Younes A et al. Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non- Hodgkin’s lymphoma and Hodgkin’s disease. Clin Cancer Res 2004;10(16):5432-8. Abstract